Loading provider…
Loading provider…
Dermatology Physician in Los Angeles, CA
NPI: 1063494474Primary Practice Location
Wallace Medical Group, Inc
231 W Vernon Ave, Los Angeles, CA
Primary Employer
Wallace Medical Group, Inc
wallacederm.com
HQ Phone
Get MD Paul's Phone Numberphone_androidMobile
Get MD Paul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2027
King Drew School of Medicine
Plastic and Reconstructive Surgery • 1993 - 1994
1993 - 1994
Charles R Drew University
Residency • Dermatology
1990 - 1992
Charles R Drew Medical Center
Internship • Transitional Year
1989 - 1990
OU College of Medicine
medicine.ouhsc.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 172 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 29 | 29 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 25 |
| 4 | 11104Punch biopsy of single skin lesion | 12 | 14 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 12 | 12 |
Authors: Chen, George L, Liu, Hong, Zhang, Yali, Thomas, Julie, Ross, Maureen, Wang, Eunice S, Block, AnneMarie W, Sait, Sheila, Deeb, George, Wallace, Paul, Wetzler, Meir, Hahn, Theresa, McCarthy, Philip L
Journal: Biol Blood Marrow Transplant
Publication Date: 2014-05-24
Authors: Daniele, Gianlorenzo, Weinstein, Richard N, Wallace, Paul Wesley, Palmieri, Vincenzo, Bianco, Massimiliano
Journal: Phys Sportsmed
Publication Date: 2016-09-06
Rapid weight gain in professional boxing and correlation with fight decisions: analysis from 71 title fights.
Authors: Richard Weinstein
Publication Date: 2016-08-27
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: OTHER: Placebo, DRUG: BMS-986322
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Lebrikizumab
Lead Sponsor: Janssen Research & Development, LLC
Intervention / Treatment: DRUG: Placebo, DRUG: Guselkumab